Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Abstract

Hormonal contraceptives were associated with increased BC risk for <i>BRCA1</i> mutation carriers, especially if used for longer durations. Decisions about their use in women with <i>BRCA1</i> mutations should carefully weigh the risks and benefits for each individual.